1Sexually Transmitted Disease Treatment Guidelines 2002. Genters for Disease control and prevention. MMWR, 2002,51 ( RR6 ) : 45 - 48.
2Saporiti AM, GomezD, Levalle S, et al. Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use[J]. Rev Argent Microbiol,2001,33(4) :217-222.
3Lockhart SR,Reed BD, Pierson CL, et al. Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuf fling": demonstration by sequential DNA fingerprinting with probes Ca3, Cl, and CARE2 +. J Clin. Microbiol, 1996, 34 ( 4 ) : 767-777.
4Sullivan D , Coleman D. Candida dubliensis: characteristics and identification. J Clin Microbiol,1998,36(2) :329-334.
5Alvarez - Olmos MI . Barousse MM , Raian L , et al . Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex Transm Dis, 2004,31(7): 393-400.
6Spinillo A, Capuzzo E, Gulminetti R, et al. Prevalence of and risk factors for fungal vaginit is caused by non-albicans species. Am J Obstet Gynecol,1997,177(2) :485-486.
7Spinillo A,Pizzoli G, Colonna L,et al. Epidemiologic characteristic of women with idiopathic RVVC. Obstet Gynecol, 1993, 81 (5): 721-727.
8Magliani W,Conti S,Salati A,et al. New strategies for treatment of candida vaginal infections. Rew Iberoam Micol, 2005,19 ( 3 ): 144 - 148.
9Loeffler J, Hebart H, Magga S, et al. Identification of rare Candida species and other yeasts by polymerase chainreaction and slot blot. Hybridization, 2000,38(4): 767 -777.
10Deva R, Ciccoli R, Kockl, et al. Involvements of as-pirin-sensitive oxylipins in Vulvovaginal[J]. FEMSM i - crobiol. Lett, 2001,198 (1) :37-43.
